Farmer covers the Healthcare sector, focusing on stocks such as SAGE Therapeutics, Biomea Fusion, and Arcellx Inc. Currently, the analyst consensus on AbSci is a Strong Buy with an average price ...
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report)’s share price rose 5.1% on Wednesday after UBS Group raised their price target on the stock from $106.00 to $114.00. UBS Group currently has a buy rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback